A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents (Q42288163)
Jump to navigation
Jump to search
scientific article published on April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents |
scientific article published on April 2013 |
Statements
1 reference
A randomized, controlled, phase 1/2 trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in healthy children and adolescents (English)
1 reference
1 reference
Kathrin U Jansen
1 reference
Helen S Marshall
1 reference
Peter C Richmond
1 reference
Qin Jiang
1 reference
Shannon L Harris
1 reference
Thomas R Jones
1 reference
John L Perez
1 reference
1 April 2013
1 reference
1 reference
32
1 reference
4
1 reference
364-371
1 reference
Identifiers
1 reference
1 reference